Khaled Qanud

The PPARα Activator Fenofibrate Slows Down the Progression of the Left Ventricular Dysfunction in Porcine Tachycardia-Induced Cardiomyopathy

Macrophages in immunoregulation and therapeutics

Role of diet and fuel overabundance in the development and progression of heart failure

Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury

Delivery technologies for cancer immunotherapy

Activation and Regulation of Purinergic P2X Receptor Channels

PPAR control of metabolism and cardiovascular functions

Molecular mechanisms and clinical applications of angiogenesis

VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond

Myocardial Fatty Acid Metabolism in Health and Disease

Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release

Vascular Endothelial Growth Factor-B Acts as a Coronary Growth Factor in Transgenic Rats Without Inducing Angiogenesis, Vascular Leak, or Inflammation

Cardiac Energy Metabolism in Obesity

Receptors for Purines and Pyrimidines

Chronic Activation of Peroxisome Proliferator-Activated Receptor-α with Fenofibrate Prevents Alterations in Cardiac Metabolic Phenotype without Changing the Onset of Decompensation in Pacing-Induced Heart Failure

Treatment of Heart Failure by a Methanocarba Derivative of Adenosine Monophosphate: Implication for a Role of Cardiac Purinergic P2X Receptors

Reverse changes in cardiac substrate oxidation in dogs recovering from heart failure

Intramyocardial VEGF-B ₁₆₇ Gene Delivery Delays the Progression Towards Congestive Failure in Dogs With Pacing-Induced Dilated Cardiomyopathy

Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs